Redwoods Merger Partner ANEW Medical Announced A Patent In China For The Use Of ANEW's Klotho Protein And Klotho Gene Delivery And Expression Systems In The Treatment Of Cognition, Memory And Neurodegenerative Diseases

ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. In May 2023, ANEW announced its proposed merger with a special purpose acquisition company ("SPAC") called Redwoods (NASDAQ:RWOD).